Search - tctmd.com

Displaying 361 - 380 of 602

Sort: Relevancy | Date

Presentation TCT 2013

Renal Denervation with Covidien Oneshot Device: One Simple and One Not-So-Simple Case

Presenter: Dierk Scheinert

October 31, 2013

Presentation TCT 2013

Noninvasive Evaluation of Resistant Hypertension: Two Case Examples

Presenter: Michael Jaff

October 31, 2013

Presentation TCT 2013

Noninvasive Evaluation and Treatment of Resistant Hypertension

Presenter: C. Venkata S. Ram

October 31, 2013

Presentation TCT 2013

Renal Intervention: Indications and Patient Selection 2013

Presenter: Christopher White

October 30, 2013

Presentation TCT 2013

Renal Denervation Beyond Hypertension: Status Update and Study Pathways for New Clinical Indications

Presenter: Felix Mahfoud

October 30, 2013

Presentation TCT 2013

Managing the Parade of New Renal Denervation Technology: Are the Clinical Results Generalizable or Device Specific?

Presenter: Robert Whitbourn

October 30, 2013

Presentation TCT 2013

Important Lessons from SIMPLICITY HTN-3 (Inclusion Criteria, Site Selection, and Study Endpoints): What I Would Do Differently Next Time?

Presenter: Deepak Bhatt

October 30, 2013

Presentation TCT 2013

Flash Lecture #3: Renal Denervation: Beyond Hypertension!

Presenter: Fabio Brito Jr.

October 30, 2013

Presentation TCT 2013

Flash Lecture #2: Renal Denervation: Summary of Clinical Evidence

Presenter: Henrique Carvalho

October 30, 2013

Presentation TCT 2013

Flash Lecture #1: Renal Denervation: Basic Concepts, Physiological Rationale, Device Options and Procedure Steps

Presenter: Luciana Armaganijan

October 30, 2013

Presentation TCT 2013

Expanding Clinical Indications: Moderate Hypertension and Replacing (vs. Supplementing) Medical Pharmacotherapy

Presenter: Krishna Rocha-Singh

October 30, 2013

Presentation TCT 2013

Case #2: Can Renal Denervation Reduce the Frequency of Ventricular Arrhythmias in Electrical Storm?

Presenter: Luciana Armaganijan

October 30, 2013

Presentation TCT 2013

Case #1: Left Ventricular Hypertrophy Regression and Improved Glycemic Control

Presenter: Pedro de Araujo Goncalves

October 30, 2013

Presentation TCT 2013

Are Sham Controls Needed for Future Renal Denervation Studies?

Presenter: Ajay Kirtane

October 30, 2013

Presentation TCT 2013

TCT-66. Risk stratification after endovascular treatment in claudicant patients with Iliofemoral artery disease

Presenter: Miura Takashi

October 29, 2013

Presentation TCT 2013

TCT-63. Drug-Coated Balloon (DCB) for Peripheral Arteries: Postdilatation of Nitinolstents with DCB or plain balloon in the superficial femoral artery – Interim results of the...

Presenter: Karl-Ludwig Schulte

October 29, 2013

Presentation TCT 2013

TCT-62. Preliminary Result of the Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the Maya Medical OneShot™ Ablation System (RAPID) Study.

Presenter: Stefan Verheye

October 29, 2013

Presentation TCT 2013

TCT-61. Optimized External Focused Ultrasound for Renal Sympathetic Denervation – Wave II trial

Presenter: Petr Neuzil

October 29, 2013

Presentation TCT 2013

TCT-60. Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry

Presenter: Felix Mahfoud

October 29, 2013

Presentation TCT 2013

TCT-59. Longer term safety and efficacy of sympathetic renal artery denervation using a multi-electrode renal artery denervation catheter in patients with drug-resistant...

Presenter: Stephen Worthley

October 29, 2013

Advertisement

Renal Denervation with Covidien Oneshot Device: One Simple and One Not-So-Simple Case

Noninvasive Evaluation of Resistant Hypertension: Two Case Examples

Noninvasive Evaluation and Treatment of Resistant Hypertension

Renal Intervention: Indications and Patient Selection 2013

Renal Denervation Beyond Hypertension: Status Update and Study Pathways for New Clinical Indications

Managing the Parade of New Renal Denervation Technology: Are the Clinical Results Generalizable or Device Specific?

Important Lessons from SIMPLICITY HTN-3 (Inclusion Criteria, Site Selection, and Study Endpoints): What I Would Do Differently Next Time?

Flash Lecture #3: Renal Denervation: Beyond Hypertension!

Flash Lecture #2: Renal Denervation: Summary of Clinical Evidence

Flash Lecture #1: Renal Denervation: Basic Concepts, Physiological Rationale, Device Options and Procedure Steps

Expanding Clinical Indications: Moderate Hypertension and Replacing (vs. Supplementing) Medical Pharmacotherapy

Case #2: Can Renal Denervation Reduce the Frequency of Ventricular Arrhythmias in Electrical Storm?

Case #1: Left Ventricular Hypertrophy Regression and Improved Glycemic Control

Are Sham Controls Needed for Future Renal Denervation Studies?

TCT-66. Risk stratification after endovascular treatment in claudicant patients with Iliofemoral artery disease

TCT-63. Drug-Coated Balloon (DCB) for Peripheral Arteries: Postdilatation of Nitinolstents with DCB or plain balloon in the superficial femoral artery – Interim results of the...

TCT-62. Preliminary Result of the Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the Maya Medical OneShot™ Ablation System (RAPID) Study.

TCT-61. Optimized External Focused Ultrasound for Renal Sympathetic Denervation – Wave II trial

TCT-60. Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry

TCT-59. Longer term safety and efficacy of sympathetic renal artery denervation using a multi-electrode renal artery denervation catheter in patients with drug-resistant...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content